Table 1 Description of CRISP1 baseline cohort at time of the baseline questionnaire in 2014 by CRS-related utilization patterns from 2014–2019
From: Sex differences in healthcare utilization for chronic rhinosinusitis: a prospective cohort study
Variable | Full cohort | Minimal utilization | No CRS-related utilization | CRS-related utilization in one year | Episodic CRS-related utilization | Discontinued CRS-related utilization | Repeated CRS-related utilization |
|---|---|---|---|---|---|---|---|
Number (%) | 7847 (100) | 1245 (15.9) | 4,194 (53.4) | 1,293 (16.5) | 234 (3.0) | 334 (4.3) | 547 (7.0) |
Age (years), n (%)1 | |||||||
 18 to < 30 | 639 (8.1) | 177 (14.2) | 328 (7.8) | 78 (6.0) | 16 (6.8) | 21 (6.3) | 19 (3.5) |
 30 to < 45 | 1420 (18.1) | 188 (15.1) | 759 (18.1) | 252 (19.5) | 52 (22.2) | 63 (18.9) | 106 (19.40 |
 45 to < 55 | 1660 (21.2) | 177 (14.2) | 946 (22.6) | 291 (22.5) | 57 (24.4) | 75 (22.5) | 114 (20.8) |
 55 to < 65 | 1904 (24.3) | 193 (15.5) | 1036 (24.7) | 360 (27.8) | 61 (26.1) | 90 (27.0) | 164 (30.0) |
 65 or older | 2224 (28.3) | 510 (41.0) | 1125 (26.8) | 312 (24.1) | 48 (20.5) | 48 (20.5) | 144 (26.3) |
Sex, n (%) | |||||||
 Female | 4921 (62.7) | 693 (55.5) | 2658 (63.4) | 877 (67.8) | 149 (63.7) | 208 (62.3) | 336 (61.4) |
 Male | 2926 (37.3) | 552 (44.3) | 1536 (36.6) | 416 (32.2) | 85 (36.3) | 126 (37.7) | 211 (38.6) |
Race, n (%) | |||||||
 White | 7442 (94.8) | 1155 (92.8) | 3929 (93.7) | 1256 (97.1) | 229 (97.9) | 330 (98.8) | 543 (99.3) |
 Non-White | 405 (5.2) | 90 (7.2) | 265 (6.3) | 37 (2.9) | 5 (2.1) | 4 (1.2) | 4 (0.7) |
Ethnicity, n (%) | |||||||
 Non-Hispanic | 7437 (94.8) | 1151 (92.4) | 3939 (93.9) | 1251 (96.8) | 227 (97.0) | 328 (98.2) | 541 (98.9) |
 Hispanic | 410 (5.2) | 94 (7.6) | 255 (6.1) | 42 (3.2) | 7 (3.0) | 6 (1.8) | 6 (1.1) |
Smoking, n (%)1 | |||||||
 Current | 1142 (14.6) | 202 (16.2) | 586 (14.0) | 194 (15.0) | 38 (16.2) | 56 (16.8) | 66 (12.1) |
 Former | 2399 (30.6) | 402 (32.3) | 1241 (29.6) | 407 (31.5) | 76 (32.5) | 111 (33.2) | 162 (29.6) |
 Never | 4306 (54.9) | 641 (51.5) | 2367 (56.4) | 692 (53.5) | 120 (51.3) | 167 (50.0) | 319 (58.3) |
Med Assistance,1 n (%) | 1129 (14.4) | 162 (13.0) | 581 (13.8) | 209 (16.2) | 47 (20.1) | 58 (17.4) | 72 (13.2) |
Sinus surgery, n (%)1 | 882 (11.2) | 66 (5.3) | 299 (7.1) | 198 (15.3) | 51 (21.8) | 71 (21.3) | 197 (36.0) |
Asthma, n (%)1 | 2441 (31.1) | 344 (27.6) | 1128 (26.9) | 459 (35.5) | 89 (38.0) | 160 (47.9) | 261 (47.7) |
Allergic rhinitis, n (%)1 | 4932 (62.8) | 658 (52.9) | 2460 (58.7) | 935 (72.3) | 176 (75.2) | 256 (76.7) | 447 (81.7) |
Migraine headache, n (%)1 | 2493 (31.8) | 270 (21.7) | 1244 (29.7) | 516 (39.9) | 98 (41.9) | 152 (45.5) | 213 (38.9) |
CRS, n (%)2 | |||||||
 Current | 1873 (23.9) | 253 (20.3) | 726 (17.3) | 421 (32.6) | 96 (41.0) | 139 (41.6) | 238 (43.5) |
 Past | 2088 (26.6) | 307 (24.7) | 1043 (24.9) | 363 (28.1) | 71 (30.3) | 112 (33.5) | 192 (35.1) |
 Never | 3842 (49.0) | 670 (53.8) | 2408 (57.4) | 504 (39.0) | 66 (28.2) | 79 (23.6) | 115 (21.0) |
 Unknown | 44 (0.56) | 15 (1.2) | 17 (0.4) | 5 (0.4) | 1 (0.4) | 4 (1.2) | 2 (0.4) |
Obstruction/discharge, n (%)3 | |||||||
 Current | 619 (7.9) | 83 (6.7) | 266 (6.3) | 131 (10.1) | 31 (13.3) | 42 (12.6) | 66 (12.1) |
 Past | 649 (8.3) | 93 (7.5) | 364 (8.7) | 103 (8.0) | 19 (8.1) | 29 (8.7) | 41 (7.5) |
 Other symptom profile | 2737 (34.9) | 399 (32.1) | 1156 (27.6) | 555 (42.9) | 118 (50.4) | 184 (55.1) | 325 (59.4) |
 Never CRS | 3842 (49.0) | 670 (53.8) | 2408 (57.4) | 504 (39.0) | 66 (28.2) | 79 (23.7) | 115 (21.0) |
Pain/pressure, n (%)3 | |||||||
 Current | 689 (8.8) | 81 (6.5) | 260 (6.2) | 168 (13.0) | 38 (16.2) | 60 (18.0) | 82 (15.0) |
 Past | 906 (11.6) | 115 (9.2) | 466 (11.1) | 161 (12.5) | 33 (14.1) | 47 (14.1) | 84 (15.4) |
 Other symptom profile | 2410 (30.7) | 379 (30.4) | 1060 (25.3) | 460 (35.6) | 97 (41.4) | 148 (44.3) | 266 (48.6) |
 Never CRS | 3842 (49.0) | 670 (53.8) | 2408 (57.4) | 504 (39.0) | 66 (28.2) | 79 (23.7) | 115 (21.0) |
Smell loss, n (%)3 | Â | Â | Â | Â | Â | 19 (5.7) | Â |
 Current | 331 (4.2) | 51 (4.1) | 120 (2.9) | 71 (5.5) | 20 (8.6) | 14 (4.2) | 50 (9.1) |
 Past | 211 (2.7) | 49 (3.9) | 87 (2.1) | 28 (2.2) | 5 (2.1) | 222 (66.5) | 28 (5.1) |
 Other symptom profile | 3463 (44.1) | 475 (38.2) | 1579 (37.7) | 690 (53.4) | 143 (61.1) | 79 (23.7) | 354 (64.7) |
 Never CRS | 3842 (49.0) | 670 (53.8) | 2408 (57.4) | 504 (39.0) | 66 (28.2) |  | 115 (21.0) |
Pan-symptomatic, n (%)3 | |||||||
 Current | 234 (3.0) | 38 (3.1) | 80 (1.9) | 51 (3.9) | 7 (3.0) | 18 (5.4) | 40 (7.3) |
 Past | 322 (4.1) | 50 (4.0) | 126 (3.0) | 71 (5.5) | 14 (6.0) | 22 (6.6) | 39 (7.1) |
 Other symptom profile | 3449 (44.0) | 487 (39.1) | 1580 (37.7) | 667 (51.6) | 147 (62.8) | 215 (64.4) | 353 (64.5) |
 Never CRS | 3842 (49.0) | 670 (53.8) | 2408 (57.4) | 504 (39.0) | 66 (28.2) | 79 (23.7) | 115 (21.0) |